As Flu season approaches, a study reveals that a nasal spray vaccine may be more cost effective to administer to children
A study that has appeared in a recent issue of The American Journal of Pharmacy Benefits has analysed the cost-effectiveness of a nasal spray form of the flu vaccine versus the standard needle shot.
The study analysed data from two different clinical trials in the 2002-2003 flu season; one involving the flu nasal spray, and the other the standard flu jab. The authors of the study looked at data of children between the ages of 2 and 17.
The results of study revealed that amongst 10,000 flu vaccinated children, administration of the nasal spray flu vaccine resulted in fewer incidences of influenza compared to the standard shot.
The study included a number of factors to calculate cost-effectiveness, including: the number of influenza cases that would be expected based on the type of vaccine administered, the cost of each type of vaccine, the cost of being admitted into hospital for a case of the flu and the cost of a not being able to go to work (for parents.)
The study concluded that the more severe a flu season is, the more cost-effective it is to administer the nasal spray vaccine to children.